Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Early pharmacokinetic evaluation of anti-tubercular treatment as a good indicator of treatment success in pulmonary tuberculosis patients on a retreatment regimen
Patients with pulmonary tuberculosis (PTB) who fail therapy or develop a relapse are initiated on a retreatment regimen. These patients are at high risk for adverse outcomes. This study aimed to assess the rel...
-
Chapter
Repurposing of Carbapenems for the Treatment of Drug-Resistant Tuberculosis
The World Health Organization (WHO) estimated that there were 1.6 million deaths worldwide in 2017 from tuberculosis (TB). Today, TB kills more humans than any other infectious agent, even surpassing HIV/AIDS ...